Genocea Initiates Restructuring and Announces Plan to Explore Strategic AlternativesGlobeNewsWire • 04/28/22
Genocea Biosciences Stock Dives After Early Data From GEN-011 Trial In Pretreated Solid Tumor PatientsBenzinga • 04/08/22
Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR 2022GlobeNewsWire • 04/08/22
Genocea Biosciences, Inc. (GNCA) CEO William Clark on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/10/22
Genocea to Host Fourth Quarter 2021 Corporate Update Conference Call & WebcastGlobeNewsWire • 03/03/22
Genocea to Present at the 11th Annual SVB Leerink Global Healthcare ConferenceGlobeNewsWire • 02/11/22
Genocea Biosciences' (GNCA) CEO Chip Clark on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 10/28/21
Genocea to Host Third Quarter 2021 Corporate Update Conference Call & WebcastGlobeNewsWire • 10/21/21
Jennifer Herron, of ADC Therapeutics, Joins Genocea Biosciences' Board of DirectorsGlobeNewsWire • 09/13/21
Do Options Traders Know Something About Genocea (GNCA) Stock We Don't?Zacks Investment Research • 08/23/21